Entrar/Registro  
HOME SPANISH
 
Cirujano General
   
MENU

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board






>Journals >Cirujano General >Year 2016, Issue 3


Barahona-López DM, Laínez-Mejía JL, Sánchez-Sierra LE, Matute-Martínez CF, Perdomo-Vaquero R
Fournier’s gangrene at the Hospital Escuela Universitario of Tegucigalpa, Honduras
Cir Gen 2016; 38 (3)

Language: Español
References: 30
Page: 123-128
PDF: 4. Kb.


Full text




ABSTRACT

Fournier’s gangrene is a necrotizing fasciitis of polymicrobial origin that affects fascia and subcutaneous tissues of the genital and perianal regions; this condition carries a high risk of morbidity and mortality due to the rapid spread that the process can have. Objective: To contribute to the knowledge of this disease by establishing a clinical characterization of patients treated at the University Hospital. Material and methods: An observational, descriptive, retrospective study of 40 cases that were reviewed between 2010 and 2015; their epidemiological, clinical and treatment data were evaluated. Results: Of the 40 people who were included, 37 were male and three female, establishing a ratio of 12:1. The average age was 51 years; we found increased incidence in the fifth and sixth decades of life. The main clinical manifestation was pain, in the 90.0% of the patients, followed by fever, in 67.5%, and purulent discharge, in 55.0%; the main related factor was diabetes mellitus, present in 37.5% of the participants. Proteus mirabilis was the most frequently isolated organism in crop secretion, followed by Escherichia coli. Conclusions: Although this condition is rare, complications and sequelae in patients are severe, so an early diagnosis and treatment should be established to reduce the rapid progress it can present.


Key words: Fournier’s gangrene, Fournier’s syndrome, necrotizing fasciitis.


REFERENCIAS

  1. Parra CP, Pérez ES, Patiño RM, Castañeda SS, García VJ. Actualización en fascitis necrotizante. Semin Fund Esp Reumatol. 2012; 13: 41-48.

  2. Puerto PA, García SE, Morilla GM, Rodríguez RM, Bravo SC, Urbina PAP, et al. Gangrena de Fournier: análisis descriptivo de nuestra serie de 26 pacientes. Rev Arg de Urol. 2013; 78: 90-94.

  3. Trejos-Mazariegos S, Torrealba Alonso M. Gangrena de Fournier. Revista Médica de Costa Rica y Centroamérica LXX [seriada en línea]. 2013 [citado 11 de marzo de 2016]; (606): [7 páginas].

  4. Cancino BC, Avendaño HR, Poblete AC, Guerra HK. Gangrena de Fournier. Cuad Cir. 2010; 24 (1): 28-33.

  5. Navarro-Vera JA. Gangrena de Fournier. Evid Med Invest Salud. 2010; 3: 51-57.

  6. Méndez-Rosales M, Aymaya GC, Gutiérrez CF, Huacota SM. Gangrena de Fournier pos-prostatectomía transuretral por cáncer de próstata: a propósito de un caso. Rev Med-Cient. 2011; 2: 64-67.

  7. Castillo HF, Moraga CJ, Pérez CP, Álvarez ZC, Iglesias BA. Diagnóstico y manejo precoz de la gangrena de Fournier. Rev Chil Cir. 2015; 67: 181-184.

  8. Blanco F, Caradonti M, Rivero D, Iborra F, Franceschelli A, Smolje L. Fascitis necrotizante perineal: gangrena de Fournier. Hosp Aeronaut Cent. 2014; 9: 113-120.

  9. Chennansetty A, Khourdaji I, Burks F, Killinger KA. Contemporary diagnosis and management of Fournier’s gangrene. Thev Adv Urol. 2015; 7: 203-215.

  10. López BM, Alba CJ, Guerrero AG, Améndola MA, Casillas MJ. La gangrena de Fournier: evaluación con tomografía computada. Anales de Radiología México. 2012; 12: 98-103.

  11. Akilov O, Pompeo A, Sehrt D, Bowlin P, Molina WR, Kim FJ. Early scrotal approximation after hemiscrotectomy in patients with Fournier’s gangrene prevents scrotal reconstruction with skin graft. Can Urol Assoc J. 2013; 7: E481-485.

  12. Thawaini A, Khan A, Malik A, Cherian J, Barua J, Shergill I, et al. Fournier’s gangrene and its emergency management. Postgrad Med J. 2006; 82: 516-519.

  13. Mallikarjuna MN, Vijayakumar A, Patil VS, Shivswamy BS. Fournier’s gangrene: current practices. ISRN Surgery [seriada en línea]. 2012 [citado 13 de marzo de 2016]; [8 páginas]. Disponible en: http://www.hindawi.com/journals/isrn/2012/942437/cta/

  14. García MA, Turégano FF, Cuadrado AM, Andueza LJ, Cano BJ, Pérez LM. Factores predictivos de mortalidad en la gangrena de Fournier: serie de 59 casos. Cir Esp. 2015; 93: 12-17.

  15. Laor E, Palmer LS, Tolia BM, Reid RE, Winter HI. Outcome predictions in patients with Fournier’s gangrene. J Urol. 1995; 154: 89-92.

  16. Jimenez-Pacheco A, Arrabal-Polo MA, Arias-Santiago S, Arrabal-Martin M, Nogueras-Ocaña M, Zuluaga-Gomez A. Fournier Gangrene: description of 37 cases and analysis of associated health care costs. Actas Dermosifiliogr. 2012; 103: 29-35.

  17. Urdaneta CE, Méndez PA, Urdaneta CA. Gangrena de Fournier. Perspectivas actuales. An Med Interna. 2007; 24: 190-194.

  18. Sedano-Basilio JE, Cornejo-Dávila V, Trujillo-Ortiz L, Cantellano-Orozco M, Fernández-Noyola G, Martínez-Arroyo C, et al. Experiencia y revisión de la literatura en el manejo de gangrena de Fournier en una institución 2008-2015. Rev Mex Urol. 2016; 76: 29-35.

  19. Mehl AA, Nogueira FD, Marques LM, Mamprim MM, Berger R, Krauss D, et al. Management of Fournier’s Gangrene: experience of a university hospital of Curitiba. Rev Col Bras Cir. 2010; 37: 435-441.

  20. Montoya CR, Izquierdo ME, Pietricica BN, Pellicer FE, Aguayo AJ, Miñana LB. Gangrena de Fournier. Análisis descriptivo de 20 casos y revisión de la bibliografía científica. Actas Urol Esp. 2009; 33: 873-880.

  21. Etcheverry MG, Plerini A, Brosutti O, G Ruiz, Canga V. Manejo de la Gangrena de Fournier: nuestra experiencia. RevArg Res Cir. 2015; 20: 19-21.

  22. Rodríguez VA, Larios GC, Garcia CG, Rodríguez SI, López PJ. Gangrena de Fournier. Rev Medica Sanitas. 2015; 18: 212-219.

  23. Ming-Chan H, Chia-Lin C, Li-Chin C, Chung-Han H, Ko-Chi N, Hsien-Lin C, et al. The role of hyperbaric oxygen therapy in treating extensive Fournier’s gangrene. Urological Science [seriada en línea]. 2015 [citado 13 de marzo de 2016]; [6 páginas]. Disponible en: http://www.urol-sci.com/article/S1879-5226(15)00396-6/pdf

  24. González SG, Díaz MJ, Collera RS, González GG, Romero RJ, Rivero OJ. Gangrena de Fournier. Rev Cubana Cir [seriada en línea]. 2010 [citado 13 de marzo de 2016]; 49(3): [6 páginas]. Disponible en: http://scielo.sld.cu/pdf/cir/v49n3/cir09310.pdf

  25. Azolas M R. Factores de riesgo para mortalidad en gangrena de Fournier. Rev Chil Cir. 2011; 63(3): 270-275.

  26. Ballesteros JR, Garcia-Tarriño R, Ríos M, Domingo A, Rodríguez-Roiz JM, Llusa-Pérez M, et al. Necrotizing soft tissue infections: a review. International Journal of Advanced Joint Reconstruction [seriada en línea]. 2016 [citado 13 de marzo de 2016]; 3 (1): [9 páginas]. Disponible en: http://www.healthyjoints.eu/wp-content/uploads/2016/02/2016_IJAJR_Necrotizing-soft-tissue-infections-Review.pdf

  27. Chlya PL, Igenge JZ, Mabula JB, Simbila S. Fournier’s gangrene at a tertiary health facility in northwestern Tanzania: a single centre experiences with 84 patients. BMC Research notes [seriada en línea]. 2015 [citado 13 de marzo de 2016]; 8 (481): [7 páginas]. Disponible en: http://bmcresnotes.biomedcentral.com/articles/10.1186/s13104-015-1493-1

  28. Shashireka CA, Pramod T, Nagarj KN, Kumar H, Rakesh N. Evaluation of Fournier’s gangrene severity index in the management of Fournier’s gangrene: retrospective study. Int Surg J. 2016; 3: 169-172.

  29. García A, Turégano F, Martín J, Vaquero A, Camarero C, Pérez MD. Gangrena de Fournier: Análisis de una serie de 34 casos. Rev Colomb Cir. 2010; 25: 151-157.

  30. Fuentes Valdés E, Núñez Roca A, Kapaxi Andrade J, Fernandes da Cunha Y. Gangrena de Fournier. Rev Cubana Cir. 2013; 52: 91-100.






>Journals >Cirujano General >Year 2016, Issue 3
 

· Journal Index 
· Links 






       
Copyright 2019